GZMB and type 2 diabetes mellitus: In insulin resistance and type 2 diabetes, circulatory granzyme B was increased, and it is a component of an inflammatory marker [35]; Yoon Kim et al. [36] showed that reduced cytotoxic expression and a low amount of apoptosis inducer were observed in natural killer cells in diabetic mice.